<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Recurrence rate of insulinoma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Recurrence rate of insulinoma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Recurrence rate of insulinoma</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Recurrence rate of insulinoma after initial curative surgery in 196 patients in the Mayo Clinic cohort (1927 to 1986). The likelihood of recurrence was greater in those patients with MEN1 (21 versus 7% at 20 years).</div><div class="graphic_footnotes">MEN1: multiple endocrine neoplasia type 1.</div><div class="graphic_reference">Courtesy of F John Service, MD.</div><div id="graphicVersion">Graphic 82017 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
